eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | craniopharyngioma |
| Comorbidity | C0028754|obesity |
| Sentences | 6 |
| PubMedID- 21234339 | As it has been reported [9] that hypothalamic damage is a risk factor for severe obesity in craniopharyngioma patients, it can be speculated that hypothalamic damage could have been responsible for disturbances in melatonin secretion. |
| PubMedID- 26371051 | Hypothalamic obesity in craniopharyngioma patients: disturbed energy homeostasis related to extent of hypothalamic damage and its implication for obesity intervention. |
| PubMedID- 22506774 | Objective: to retrospectively analyse the effectiveness of bariatric surgery for hypothalamic obesity in patients with craniopharyngioma (cp). |
| PubMedID- 21846381 | Nevertheless, the aetiology of obesity in craniopharyngioma is not yet fully understood. |
| PubMedID- 20367360 | Object: obesity as a consequence of management of pediatric craniopharyngioma is a well-described phenomenon related to the degree of hypothalamic involvement. |
| PubMedID- 24904871 | Recent data has shown that hypothalamic obesity patients with craniopharyngioma have decreased urinary homovanillic acid and vanillylmandelic acid, indicating reduced sympathetic tone40). |
Page: 1